Amyloid P-IN-1 is primarily used in research settings to study its potential in inhibiting serum amyloid P component (SAP), a protein associated with amyloidosis and other inflammatory diseases. Its application is significant in exploring therapeutic strategies for conditions like Alzheimer's disease, systemic amyloidosis, and other disorders where amyloid deposits play a critical role. Researchers utilize this compound to investigate its efficacy in reducing amyloid fibril formation, which could pave the way for novel treatments targeting amyloid-related pathologies. Additionally, it serves as a valuable tool in understanding the mechanisms of amyloid deposition and clearance in the body.